查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1331133

螺虫乙酯全球市场

Spirotetramat
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，螺虫乙酯全球市场将达到 3.067 亿美元

在不断变化的后COVID-19商业环境中，螺虫乙酯的全球市场预计2022年为2.122亿美元，预计到2030年将达到3.067亿美元，从2022年到2030年不断增长。预计年复合成长率同比增长 4.7%。

美国市场估计为5640万美元，中国预计年复合成长率为7.1%

2022年美国螺虫乙酯市场估计为5640万美元。中国作为世界第二大经济体，预计在2022年至2030年的分析期间将以7.1%的年复合成长率增长，2030年市场规模将达到6680万美元。其他值得注意的地域市场包括日本和加拿大，预计 2022 年至 2030 年将分别增长 2.9% 和 3.8%。在欧洲，德国预计年复合成长率约为 3.7%。

受访企业示例

  • Bayer CropScience

目录

第1章调查方法

第2章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和促进因素
  • 全球市场预测

第3章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 意大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳大利亚
  • 印度
  • 韩国
  • 亚太地区其他地区
  • 拉美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙特阿拉伯
  • 阿拉伯联合酋长国
  • 其他中东地区
  • 非洲

第4章竞争

简介目录
Product Code: MCP16046

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Spirotetramat Market to Reach $306.7 Million by 2030

In the changed post COVID-19 business landscape, the global market for Spirotetramat estimated at US$212.2 Million in the year 2022, is projected to reach a revised size of US$306.7 Million by 2030, growing at a CAGR of 4.7% over the period 2022-2030.

The U.S. Market is Estimated at $56.4 Million, While China is Forecast to Grow at 7.1% CAGR

The Spirotetramat market in the U.S. is estimated at US$56.4 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$66.8 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 3.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Select Competitors (Total 46 Featured) -

  • Bayer CropScience

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Spirotetramat - Global Key Competitors Percentage Market Share in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Spirotetramat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Spirotetramat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Spirotetramat by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Spirotetramat Market Analysis of Annual Sales in US$ for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 5: USA Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 6: USA Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • CANADA
    • TABLE 7: Canada Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 8: Canada Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • JAPAN
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 9: Japan Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 10: Japan Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • CHINA
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 11: China Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 12: China Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • EUROPE
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 13: Europe Recent Past, Current & Future Analysis for Spirotetramat by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 14: Europe Historic Review for Spirotetramat by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 15: Europe 16-Year Perspective for Spirotetramat by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
  • FRANCE
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 16: France Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 17: France Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • GERMANY
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 18: Germany Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 19: Germany Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • ITALY
    • TABLE 20: Italy Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 21: Italy Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • UNITED KINGDOM
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 22: UK Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 23: UK Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • SPAIN
    • TABLE 24: Spain Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 25: Spain Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • RUSSIA
    • TABLE 26: Russia Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Russia Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • REST OF EUROPE
    • TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Rest of Europe Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • ASIA-PACIFIC
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Spirotetramat by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 31: Asia-Pacific Historic Review for Spirotetramat by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 32: Asia-Pacific 16-Year Perspective for Spirotetramat by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
  • AUSTRALIA
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 33: Australia Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 34: Australia Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • INDIA
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 35: India Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 36: India Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • SOUTH KOREA
    • TABLE 37: South Korea Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 38: South Korea Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • REST OF ASIA-PACIFIC
    • TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 40: Rest of Asia-Pacific Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • LATIN AMERICA
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 41: Latin America Recent Past, Current & Future Analysis for Spirotetramat by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 42: Latin America Historic Review for Spirotetramat by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 43: Latin America 16-Year Perspective for Spirotetramat by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 44: Argentina Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Argentina Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • BRAZIL
    • TABLE 46: Brazil Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Brazil Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • MEXICO
    • TABLE 48: Mexico Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Mexico Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • REST OF LATIN AMERICA
    • TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Rest of Latin America Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • MIDDLE EAST
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 52: Middle East Recent Past, Current & Future Analysis for Spirotetramat by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 53: Middle East Historic Review for Spirotetramat by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
    • TABLE 54: Middle East 16-Year Perspective for Spirotetramat by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
  • IRAN
    • TABLE 55: Iran Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 56: Iran Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • ISRAEL
    • TABLE 57: Israel Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 58: Israel Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • SAUDI ARABIA
    • TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Saudi Arabia Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • UNITED ARAB EMIRATES
    • TABLE 61: UAE Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 62: UAE Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • REST OF MIDDLE EAST
    • TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 64: Rest of Middle East Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
  • AFRICA
    • Spirotetramat Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 65: Africa Recent Past, Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Africa Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

IV. COMPETITION